Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical's business focus is the development of commercial applications for their proprietary technologies. The scientific team is on the leading edge of the proteomics industry through their discovery of protein footprints, pathways, and mechanisms of disease. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer, neurodegenerative disease and drug resistance in cancer.

PWRM is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory.

The NuroPro Blood Test is Power3’s diagnostic tool for the early detection of Neurodegenerative diseases. ( Read More http://crweselect.com/22299/stock-alerts/pwrm-ppwe-gild-ual-rvbd-crwesel... )